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ABSTRACT 
Objectives 
Identification of early Alzheimer’s disease (AD) has become very important. Episodic 
memory tasks appear to have predictive power for indicating early AD. Deficits in 
encoding and storage processes that are characteristic of AD however must be 
distinguished from non-AD deficits that can also affect memory, including difficulties 
that may be present in depression.This pilot study was set up to ascertain whether a 10 
word-list-learning task (delayed recognition and rate of forgetting) may be useful in 
making the differentiation between mild AD and depression.  
Method 
A Dutch version of Rey’s Auditory Verbal Learning Test was administered to 36 mild 
AD patients, 41 depressed patients and 47 healthy controls. Data were analyzed cross 
sectional.  
Results 
ROC analyses showed that for differentiating mild AD and depression, both delayed 
recognition and percentage of forgetting have sufficient diagnostic accuracy. 
Conclusion 
Percentage of forgetting had the highest diagnostic accuracy for differentiating mild 
AD and depressed patients and may be useful in the early detection of AD.   
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Introduction 
The development of pharmacological treatment options for Alzheimer’s Disease (AD) 
that aim to modify the disease process increases the need for early diagnosis of AD 
(Swainson et al., 2001). Patients might benefit from cognition-enhancing or future 
disease-modifying drugs (Sonkusare, Kaul, & Ramarao, 2005). Due to an 
unprecedented growth of scientific knowledge, Dubois et al. (2007) proposed revised 
diagnostic research criteria for AD. These new criteria are centered on a clinical core 
of early and significant episodic memory impairment (together with supportive 
biomarker criteria). Episodic memory tasks appear to have predictive power for early 
AD, as the episodic memory function is anatomically located within the medial 
temporal lobe structures, including the hippocampus. These structures contain the 
highest densities of AD neuropathological lesions. Most studies that have addressed 
the issue of early detection of AD have emphasized the diagnostic value of delayed 
free recall deficits. However, impaired delayed recall is not in itself evidence of an 
AD-related disorder. The genuine deficits in encoding and storage processes that are 
characteristic of AD must be distinguished from non-AD deficits that can also affect 
delayed recall, including difficulties that may be present in depression (Dubois et al., 
2007). 
This study was set up to ascertain whether a 10-word-list learning task (10-RAVLT) 
(a standardized Dutch variation of Rey’s Auditory Verbal Learning Test) incorporated 
in a Dutch dementia battery (VVKP Werkgroep Klinische gerontopsychologie, 1998), 
may be useful in differentiating between mild AD and depression in elderly patients. 
The usefulness of the concepts of (1) recognition and (2) rate of forgetting will be 
studied in the light of early diagnosis.       
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Generally speaking, memory processes can be divided into three different successive 
phases, namely (1) acquisition or encoding, (2) consolidation, and (3) retrieval 
(Tuokko & Hadjistavropoulos, 1998). 
Several studies (Perry, Watson, & Hodges, 2000; Au, Chan, & Chiu, 2003) have 
shown that the impairment of acquisition and, more specially, the consolidation of 
episodic memory traces are the earliest signs of the underlying degenerative process 
of AD. This process originates in the medial temporal lobe, in particular in the 
entorhinal cortex and the hippocampus (Karrasch, Sinerva, Gronholm, Rinne, & 
Laine, 2005). Therefore, assessment of encoding and consolidation may be useful by 
detecting subtle entorhinal or hippocampal dysfunctions. 
 
Recognition 
Delayed recall involves the retrieval of a previously encoded word, whereas delayed 
recognition measures only whether or not a word has been encoded and consolidated 
(Shankle et al., 2005). In contrast to patients with mild AD, who may fail to 
consolidate information effectively, depressed patients may demonstrate essentially 
normal memory consolidation (Hart, Kwentus, Taylor, & Harkins, 1987). In general, 
it is assumed that depressed elderly patients show normal delayed recognition (Fossati 
et al., 2004). In summary, we assume that among AD patients, due to consolidation 
deficits, delayed recognition performance will be very poor, whereas depressed 
patients will show normal delayed recognition.  
 
Rate of forgetting 
AD patients fail to consolidate information effectively (Hart, Kwentus, Taylor, & 
Harkins, 1987; Perry et al., 2000). Moreover, it has indeed been shown (Kopelman, 
1992) that in AD patients information rapidly disappears from episodic memory, 
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whereas in elderly depressed patients there is no retention deficit (Fossati et al., 2004; 
Bearden et al., 2006). The rate of forgetting paradigm may thus be clinically useful for 
distinguishing patients with early AD from elderly depressed patients (Hart, Kwentus, 
Taylor, & Harkins, 1987). Forgetting can be defined as a decrease in performance 
over time represented by the slope of a line connecting the acquisition terminus to 
performance at follow-up (MacDonald, Stigsdotter-Neely, Derwinger, & Backman, 
2006). In most cases, delayed free recall has been used to operationalize this rate of 
forgetting. Because there is always a possibility that differences in forgetting rates 
result in part from poor initial learning rather than from differences in the ability to 
retain information over time, we argue that it might be better to operationalize the rate 
of forgetting not by means of delayed free recall, but by means of the percentage of 
forgetting in which the amount of initially learned information is taken into account 
(Estevez-Gonzalez, Kulisevsky, Boltes, Otermin, & Garcia-Sanchez, 2003). Given the 
fact that AD patients have more difficulty retaining information than depressed 
elderly patients, one could argue that the percentage of forgetting will be higher in AD 
patients than in depressed patients. 
 
Aim and objectives 
In general, we wanted to ascertain whether the 10-RAVLT, which is a widely and 
frequently used verbal learning task, could be used in the early differentiation between 
mild AD and depression in elderly patients. 
We hypothesized that (1) AD patients would obtain lower scores on delayed 
recognition, whereas depressed elderly patients would have normal recognition scores 
and that (2) unlike depressed patients, who are able to retain information over time, 
AD patients would show a higher percentage of forgetting. 
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Methods and measures 
The results of this cross-sectional study were obtained between March 2004 and May 
2005. 
Participants 
The inclusion criteria of the study population were as follows: (1) a diagnosis of 
probable AD, according to the DSM-IV and NINCDS-ADRDA criteria (American 
Psychiatric Association, 1994; McKhann et al., 1984) or (2) a diagnosis of major 
depression, according to the DSM-IV criteria (American Psychiatric Association, 
1994) established by the clinicians in the institutions (neurologists in the memory 
clinic and psychiatrists in the psychiatric institutions) following an elaborate workup 
consisting of a general physical and neurological examination, blood screening, 
structural neuroimaging (consisting of a computerized tomography scan of the brain 
and/or magnetic resonance imaging and functional brain imaging - single photon 
emission computed tomography (SPECT)), and an electroencephalogram, as well as 
an extensive neuropsychological examination consisting of tests other than those 
included in this study administered by the institutions’ psychologists. Additionally, a 
comprehensive clinical interview was performed by the clinician to diagnose major 
depression. This procedure was carried out in the memory clinic and in the psychiatric 
institutions where most of the depressed patients were recruited. 
AD patients who scored over 19 on the Mini Mental State Examination (MMSE) 
(Folstein, Folstein, & McHugh, 1975) were classified as mildly demented. Because 
the differentiation between depression and AD is most difficult in the earliest stages 
of AD, only mild AD patients were included in the analyses. 
The exclusion criteria were the presence of a bipolar disorder or a psychotic 
depression and the presence of a delirium according to the Confusion Assessment 
Method (CAM) (Inouye et al., 1990). 
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Allocation to the 2 patient groups was based on the diagnosis carried out by the 
clinicians in the institutions. When an AD patient appeared to have significant 
depressive symptoms, he/she was classified in the AD group. All the patients who met 
the inclusion criteria were asked by the clinicians in the institutions to take part in the 
study. The study population consisted of 77 patients (mild AD: n=36; depression: 
n=41) who were prospectively recruited in a memory clinic (AD: n=30; depression: 
n=2) and in psychiatric hospitals (AD: n=6; depression: n=39). 
The healthy controls were recruited from the general population (by contacting senior 
citizens’ associations). The inclusion criteria of this healthy control group (n=47) 
were: (1) no history of neurological or psychiatric disease, (2) no active psychiatric 
disorder, and (3) no organic diseases involving the central nervous system. This 
information was obtained by asking the subjects questions by means of a structured 
interview. Other inclusion criteria were: MMSE > 23 and Geriatric Depression Scale 
score (GDS) (Yesavage, 1988) < 11, indicating the absence of severe cognitive and 
affective problems. The MMSE and GDS scores were both gathered by the 
researcher. 
 
Measures 
The MMSE, a short screening instrument for cognitive functions, the GDS, a scale to 
assess depressive symptoms, the 10-RAVLT, a 10-word-list verbal learning task, and 
the Raven Coloured Progressive Matrices (RCPM) (Raven, 1984) as a non-verbal 
interference task were administered to all subjects. 
 
10-RAVLT 
The 10-RAVLT is a word-list learning task (10 unrelated words) consisting of 5 
consecutive free recall trials and a recall (delayed recall) trial after an interference 
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period. Additionally there is also a delayed recognition trial. The 10 nouns are read 
aloud, with a 2-seconds interval between each word, by the examiner, for 5 
consecutive trials (trials 1 to 5), each trial followed by a free recall test. Patients are 
instructed that they will hear a list of 10 words and that they will be asked to repeat as 
many words as possible. The order, in which the words are presented, remains fixed 
across trials. Instructions are repeated before each trial in order to minimize 
forgetting. After a 20-minute delay period, in which non-verbal activities are carried 
out (in this study the RCPM is administered), each subject is again asked to recall as 
many words as possible (delayed recall trial). In the delayed recognition trial, patients 
have to point out whether the given word was in the original list or not (10 target 
words are presented among 10 distracters). Hits and correct rejections are recorded.  
 
MMSE 
The MMSE is a structured test used to assess general cognitive status in an older adult 
population with good psychometric properties (Folstein, Folstein, & McHugh, 1975).  
 
GDS 
The GDS, consisting of 30 items, was developed as a basic screening measure for 
depression in older adults. The items should be answered by ‘yes’ or ‘no’. A score of 
11 or lower is the threshold separating depressed patients (≥ 11) from non-depressed 
patients (<11) (Jongenelis et al., 2005). 
 
Procedure 
The study was approved by the local ethics committees. Written informed consent 
was obtained from all subjects.  
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After a diagnosis was made by the clinicians in the institutions, the test instructor (all 
subjects were tested by the same research psychologist), who was not blinded for the 
clinical diagnosis, administered the MMSE, the GDS, the 10-RAVLT, and the RCPM 
to all subjects. These tests were part of a larger research test battery that took +/- 60 
minutes to administer. For this study, only the results of the MMSE, the GDS and the 
10-RAVLT were used. For a detailed description of the other measures we refer to 
Dierckx et al. (2007) and Dierckx et al. (2008).  
 
To ascertain whether depressed patients obtain higher scores on recognition, the 
delayed recognition task was used (a maximum score of 20 could be obtained: 10 for 
the hits and 10 for the correct rejections). To check the hypothesis that rate of 
forgetting is higher among AD patients than among depressed elderly patients, a 
percentage of forgetting was calculated as follows “100 x difference between the 
number of words correctly recalled after the fifth reading and at the delayed recall test 
/ number of words correctly recalled during the fifth trial” (see Estévez-Gonzalez et 
al., 2003).   
 
Statistical analyses 
Intergroup differences in age, years of education, delayed recognition scores and 
percentage of forgetting were examined using one way analysis of variance 
(ANOVA). If significant main effects were shown, Scheffé post hoc analyses were 
performed. Intergroup differences in gender and use of benzodiazepines, 
antidepressants and antipsychotics were analyzed using chi-square tests. A criterion 
alpha level of .05 was used throughout the analyses.  
Receiver Operating Characteristic curves (ROC curves) were drawn to determine the 
diagnostic accuracy of recognition and rate of forgetting in discriminating AD patients 
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from depressed patients. When an Area Under the ROC Curve (AUC) of more than 
.80 was achieved an ideal cut off point with the highest sensitivity (S) and specificity 
(Sp) was determined. Afterwards S and Sp were calculated. As the meaning of a score 
on a test and its positive and negative predictive power (PPV, NPV) depend not only 
on the test’s psychometric properties, such as sensitivity and specificity, but also on 
the rate of the disorder within the sample (Streiner, 2003), Positive and negative 
predictive values were calculated according to Bayes’ theorem (Elwood, 1993), in 
which the prevalence was taken into account. Positive and negative predictive value 
data are then presented for various AD base rates. 
A discriminant function analysis was performed to determine how well we could 
predict to which group a particular subject in our population belonged by using 
respectively the recognition and percentage of forgetting score. In order to check our 
assumption that percentage of forgetting scores might be more accurate for the early 
differentiation between AD and depression than delayed free recall, a discriminant 
analysis was also performed with delayed free recall as independent variable. 
Percentages of correctly (and incorrectly) identified mild AD and depressed elderly 
patients were obtained.    
Data were analyzed using SPSS for Windows 16.0.  
 
Results 
Demographic variables  
Table 1 lists the descriptive variables of the 3 groups with respect to age, gender and 
years of education.  
A one-way ANOVA could not demonstrate significant differences in age (F (2,121) = 
1.91, p = .152) or number of years of education (F (2,121) = 2.85, p = .062) between 
the different diagnostic categories. 
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A chi square analysis revealed differences in gender distribution between the 3 
diagnostic groups (chi2 (2) = 12.88, p = .002). The depression group contained more 
women than the AD (chi2 (1) = 4.76, p = .036) and healthy control groups (chi2 (1) = 
12.93, p = .0001). However, a MANOVA with (1) recognition and (2) percentage of 
forgetting as dependent variables and diagnosis and gender as independent variables 
could not demonstrate a significant interaction effect of diagnosis and gender (F (4, 
236) = 1. 73, p = .144), nor a main effect of gender (F (2, 117) = 0.66, p = .517). 
As expected GDS-scores (i.e. the amount of depressive symptoms) were higher 
among depressed patients than among mild AD patients and healthy control subjects. 
However, a MANCOVA with (1) recognition and (2) percentage of forgetting as 
dependent variables, diagnosis as independent variable and score on the GDS as a 
covariate could not demonstrate a significant interaction effect of diagnosis and GDS 
score (F (4, 234) = 0.31, p = .869), nor a main effect of GDS score (i.e. amount of 
depressive symptoms) (F (2, 116) = 1.13, p = .625). 
 
In our study, we used a naturalistic sample of elderly subjects who received a variety 
of pharmacological treatments. Chi square analyses demonstrated that in the 
depression group more subjects were taking benzodiazepines and antidepressants 
respectively than in the AD (chi2 (1) = 22.01, p = .0001; chi2 (1) = 25.92, p = .0001), 
and healthy control group (chi2 (1) = 17.84, p = .0001; chi2 (1) = 63.46, p = .0001). No 
significant differences in use of benzodiazepines were found between subjects in the 
AD and healthy control group (chi2 (1) = 0.98, p = .371). However, there were more 
subjects in the AD (chi2 (1) = 12.90, p = .0001) group who were using antidepressant 
medication as compared to the healthy control group. A MANOVA with (1) 
recognition and (2) percentage of forgetting as dependent variables and respectively 
(1) diagnosis and benzodiazepine use and (2) diagnosis and antidepressants as 
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independent variables could not demonstrate a significant interaction effect of 
diagnosis and use of benzodiazepines (F (4, 198) = 1.26, p = . 288), nor an interaction 
effect of diagnosis and use of antidepressants benzodiazepines (F (4, 198) = 1.99, p = 
.097), nor a main effect of use of benzodiazepines (F (2, 99) = 0.15, p = .863) and 
antidepressants (F (2, 99) = 1.04, p = .356).  
As far as use of antipsychotic medication is concerned no differences were found 
between AD and depressed patients (chi2 (1) = 0.92, p = .437). More AD and 
respectively more depressed patients were taking antipsychotic medication than 
healthy control subjects (chi2 (1) = 12.73, p = .0001; chi2 (1) = 18.96, p = .0001). 
Twenty three (out of 36) mild AD patients were taking cholinesterase-inhibitors.  
In summary: all depressed patients (n=41) were taking some kind of psychotropic 
medication, as was also the case with most AD patients (28 out of 36). Only 10 (out of 
47) healthy controls were receiving psychotropic pharmacological treatment.   
 
Recognition 
A one-way ANOVA (F (2,121) = 37.61, p = .0001) and post-hoc Scheffé tests showed 
that AD patients had significantly lower sores on the delayed recognition task than 
depressed elderly patients (p=.0001) and healthy controls (p=.0001). No significant 
differences were found between depressed elderly patients and healthy controls 
(p=.423). 
When the total score of delayed recognition was distributed into hits and correct 
rejections, a one-way ANOVA with post hoc Scheffé demonstrated no significant 
differences in the total amount of hits between the mild AD and depressed patients (p 
= .793). The differences in delayed recognition mentioned above are consequently 
mainly due to significant differences in correct rejections (F (2,121) = 30.53, p = 
.0001), whereby AD patients had significantly lower sores on the amount of correct 
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rejections than depressed elderly patients (p=.0001) and healthy controls (p=.0001). 
No significant differences were found between depressed patients and healthy control 
subjects (p=.924).   
 
Rate of forgetting 
According to a one-way ANOVA, the percentage of forgetting was significantly 
different between the 3 diagnostic groups (F (2,121) = 38.25, p = .0001). Post hoc 
Scheffé tests showed that AD patients had a significantly (p=.0001) higher percentage 
of forgetting than depressed patients (p=.0001) and healthy controls (p=.0001). The 
percentage of forgetting of depressed patients and healthy control subjects was not 
significantly different (p=.894).  
 
In the differentiation between mild AD and depressed patients, for both recognition 
and percentage of forgetting scores, a statistical power of more than .80 was obtained. 
See table 2 for an overview of the mean MMSE, GDS, delayed recognition and 
percentage of forgetting scores. 
 
 
ROC-curves 
Differentiating AD patients from depressed elderly 
The AUC indicated that the delayed recognition (AUC = .83, p = .0001) and 
percentage of forgetting (AUC = .87, p = .0001) would both be considered to be good 
in differentiating AD patients from depressed elderly patients. See Fig. 1 and 2 for the 
ROC curves. 
For delayed recognition the optimal cut off point was 18/20 (sensitivity = 78 %, 
specificity = 73%) whereas for percentage of forgetting, the optimal cut off was 
determined at 60% (sensitivity = 81%, specificity = 90%).  
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Predictive power, as measured by the positive and negative predictive values, is 
presented in tables 3 and 4. 
 
Discussion 
Recognition 
It has been shown that impairment of acquisition and consolidation of episodic 
memory traces is the earliest sign of the underlying degenerative process of AD (Perry 
et al., 2000; Au, Chan, & Chiu, 2003), whereas depressed patients may demonstrate 
essentially normal memory consolidation (Shankle et al., 2005). As delayed 
recognition measures whether or not the word has been encoded and consolidated, we 
hypothesized that recognition would be a useful criterion to differentiate between 
subjects with mild AD and depressed patients. Indeed, the delayed recognition score 
of the 10-RAVLT was significantly different between AD patients and depressed 
elderly patients, with AD patients obtaining lower scores than depressed patients. The 
suggested absence of consolidation deficits among depressed patients together with 
the fact that recognition is not cognitively effortful (Fossati et al., 2004), so that the 
effects of impaired attention, inefficient strategies, motivation problems, or lack of 
initiative are minimized (Kausler, 1994), may account for good performance on 
delayed recognition among depressed patients, whereas among AD patients poor 
performance was obtained due to consolidation deficits. 
We also demonstrated that AD patients and depressed elderly patients differed only 
on their correct rejection scores, as the hit score was not significantly different 
between AD and depressed patients. This is probably due to the presence of a liberal 
bias among AD patients, whereby recognition is marked by an increased amount of 
false positives (Burt, Zembar, & Niederehe, 1995). 
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Generally speaking, our study revealed that delayed recognition of the 10-RAVLT 
may be a useful criterion on the basis of which to differentiate AD patients from 
depressed elderly patients. Indeed, the ROC curve showed that diagnostic accuracy 
was good (AUC = .83); with a cut-off point of 18 out of 20, a sensitivity of 78% and a 
specificity of 73% were obtained. 
 
Rates of forgetting 
Our study showed that AD patients could be differentiated from depressed elderly 
patients on the basis of the percentage of forgetting. AD patients showed a higher 
percentage of forgetting than depressed patients. A diagnostic accuracy of .87 was 
obtained, which can be considered good as it exceeds the minimal threshold of 80% 
defined in the generally accepted criteria for diagnostic biological markers for AD 
(The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association 
and the National Institute on Aging Working Group, 1998). With a cut-off point of 
60%, a sensitivity of 81% and a specificity of 90% were obtained. In AD patients, it 
has been shown that information is rapidly lost from episodic memory, indicating a 
failure to consolidate information effectively (Hart, Kwentus, Taylor, & Harkins, 
1987; Perry et al., 2000; Kopelman, 1992).  
As can be seen from table 5, the percentage of forgetting was a better 
operationalization of the rate of forgetting than delayed free recall: according to 
percentage of forgetting 90% of depressed patients were classified correctly, whereas 
on delayed free recall only 71% of depressed patients were correctly classified. With 
the more traditional method (i.e. delayed free recall), more depressed patients were 
thought to have mild AD. As it is known that depressed patients learn fewer words 
(e.g. Gainotti & Marra, 1994), our results support the hypothesis that it is better to 
operationalize the rate of forgetting on the basis of the percentage of forgetting, in 
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which the amount of initially learned information is taken into account, rather than on 
the basis of delayed free recall. 
 
General discussion 
In a previous study (Dierckx et al., 2007), we found that cued recall, operationalized 
by the combined scores on the Visual Association Test (Lindeboom et al., 2002) and 
on the Memory Impairment Screen-plus (Buschke et al., 1999), is a criterion that is 
useful in differentiating AD patients from depressed and healthy individuals. These 
cued recall tests therefore appeared to be very useful instruments for the 
operationalization of the new research criteria for the diagnosis of AD as proposed by 
Dubois et al. (2007), as these authors suggest that the core diagnostic criterion is the 
presence of an episodic memory impairment that consists of a recall deficit that does 
not normalize or improve significantly after cueing.  
However, this study revealed that the 10-RAVLT (a very widely and frequently used 
verbal learning test) may also be a useful instrument for the early detection of AD, 
especially when it comes to making an early differentiation between, on the one hand, 
mild AD and, on the other hand, depression and healthy aging among elderly subjects. 
Both delayed recognition and the percentage of forgetting, in our study, show a 
diagnostic accuracy (high sensitivity and specificity scores) that can be considered as 
useful criterion for differentiating between AD patients and depressed elderly patients 
and healthy controls. This is probably due to episodic memory consolidation 
problems, which are present in AD but are considered to be absent in depressed 
subjects and healthy aging subjects. However, these results are preliminary and need 
to be validated using alternate samples that include a higher number of subjects.A 
possible limitation of the present study is that we have no information of the patients 
who did meet the inclusion criteria but did not want to participate in the study. It may 
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be that the depressed patients who refused were more severely depressed. However, 
most depressed patients (n=39) scored ≥ 11/30 on the GDS, indicating the presence of 
significant depressive symptoms. Moreover, 21 patients obtained a score of more than 
20/30, indicating severe depression. We can thus assume that severe depression did 
not lead to a selection bias through the refusal to participate.  
A further limitation is that the psychologist who administered the measures to the 
subjects was not blinded to the clinical diagnosis. However, as all the measurements 
require standard administration procedures, possible results biases are minimal.     
Another possible limitation of the present study is that we used a naturalistic sample 
of elderly subjects who typically receive a variety of pharmacological treatments, 
rather than highly controlled clinical research subjects. In general, benzodiazepine use 
was more frequent among depressed elderly patients than among AD patients and 
healthy controls. Since it is well documented that benzodiazepines have a negative 
effect on cognition (Perna, 2004), this could have had an effect on delayed recognition 
and the percentage of forgetting scores. However, we obtained neither a significant 
interaction effect of group and benzodiazepine use nor a main effect of 
benzodiazepine use. 
In our study, 23 out of the 35 AD patients and none of the depressed elderly patients 
were taking cholinesterase inhibitor medication. Because a recent study (Crowell, 
Paramadevan, Abdullah, & Mullan, 2006) showed that this medication may have a 
beneficial effect on the recognition memory performance of AD patients, the use of 
cholinesterase inhibitors may have accounted for the slightly lower accuracy scores 
obtained by delayed recognition compared to the percentage of forgetting in 
differentiating AD from depressed patients.  
Furthermore, as expected, antidepressant use was more frequent among depressed 
patients. However, most of the patients were treated with serotonin reuptake 
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inhibitors, and some were receiving low-dose tricyclic antidepressant medication, 
minimizing the potential cognitive side effects. A significant interaction effect of 
diagnosis and use of antidepressants was found on the recognition task. Since there is 
some evidence to suggest that antidepressant medication might have neuroprotective 
properties, particularly in the hippocampus (Haynes, Barber, & Mitchell, 2004), the 
performance of the depressed patients on the recognition score may have been 
positively influenced by the use of antidepressant medication. However, it has been 
argued that cognitive improvement following pharmacological treatment with 
antidepressants is seen only after an improvement in depressive symptoms 
(Doraiswamy et al., 2003). In our study, all the depressed patients met the diagnostic 
criteria for major depressive disorder during the study. Moreover, delayed free recall 
is considered to be the memory measurement with the greatest sensitivity for the early 
detection of AD (Swainson et al., 2001), since it is anatomically related to the medial 
temporal lobe (Campo, Morales, & Martinez-Castillo, 2003). In our study, the 
percentage of forgetting, which is derived from the delayed free recall score, appeared 
not to be influenced by the use of antidepressants. We therefore assume that the 
influence of antidepressants on our test scores is minimal. However, to check this 
assumption future studies must be carried out with treatment-naïve patients.  
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Table 1. Sample description: demographic variables gender, age and years of 
education  
 
 
Mild AD Depression Controls 
N 36 41 47 
Male/female 13/23 6/35 24/23 
Mean (SD) age  
in years 
76.6 (6.0) 74.1 (5.2) 75.7 (5.9) 
Mean (SD) years 
of education 
10.2 (2.5) 10.4 (2.5) 11.6 (3.4) 
 
